Table 1 Frequencies of baseline clinical parameters of the study groups
Normal N (%) | DM N (%) | CAD N (%) | DM+CAD (0-5y) N (%) | DM+CAD (5-10y) N (%) | |
|---|---|---|---|---|---|
Age | |||||
> 45 | 47 (38.8) | 18 (18) | 13 (10.6) | 6 (5.9) | 3 (2.8) |
< 45 | 74 (61.1) | 83 (83) | 109 (85.3) | 97 (95.1) | 106 (97.2) |
Gender | |||||
Male | 66 (54.5) | 49 (49) | 102 (83.6) | 83 (81.4) | 78 (71.6) |
Female | 55 (48.4) | 52 (52) | 20 (16.3) | 20 (19.6) | 3 (28.4) |
FBS ( mg / dL ) | |||||
70 - 110 | 89 (73.5) | 26 (26) | 43 (35.2) | 25 (24.5) | 21 (19.3) |
> 110 | 32 (26.4) | 75 (75) | 79 (64.7) | 78 (76.5) | 88 (80.7) |
HbA1C (%) | |||||
< 5.7 | 88 (72.7) | 4 (4) | 50 (40.9) | 1 (1) | 3 (2.8) |
5.7 - 6.4 | 28 (23.1) | 6 (6) | 40 (32.70 | 19 (18.6) | 5 (4.6) |
> 6.5 | 5 (4.1) | 91 (91) | 32 (26.2) | 83 (81.4) | 101 (92.7) |
Total cholesterol ( mg / dL ) | |||||
< 200 | 64 (52.8) | 58 (58) | 90 (73.7) | 78 (76.5) | 80 (73.4) |
200 - 240 | 37 (30.5) | 36 (36) | 15 (72.2) | 12 (11.8) | 13 (11.9) |
> 240 | 20 (16.5) | 7 (7) | 17 ( (13.9) | 13 (12.7) | 16 (14.7) |
LDL ( mg / dL ) | |||||
< 100 | 91 (75.2) | 33 (33) | 78 (63.9) | 68 (66.7) | 64 (58.7) |
> 100 | 30 (24.7) | 68 (68) | 44 (36.1) | 35 (34.3) | 45 (41.3) |
HDL ( mg / dL ) | |||||
< 60 | 113 (43.3) | 90 (90) | 117 (95.9) | 100 (98) | 104 (95.4) |
> 60 | 8 (6.6) | 11 (11) | 5 (4.1) | 3 (2.9) | 5 (4.6) |
Triglycerides ( mg / dL ) | |||||
< 150 | 113 (43.3) | 90 (90) | 78 (63.9) | 64 (62.7) | 77 (70.6) |
> 150 | 8 (6.6) | 11 (11) | 44 (36.1) | 39 (38.2) | 32 (29.4) |